Ads
related to: gene therapy for sickle cell disease treatment- Safety and Side Effects
Review the Safety Profile
And Potential Side Effects.
- Find Treatment Centers
Find an Authorized Treatment Center
By Using the Map Search Feature.
- Prescribing Information
View Full Prescribing Information &
Indications And Usage.
- Mechanism of Action
See How Gene Therapy Works.
Learn the Science Behind Treatment
- Important Safety Info
View Warnings And Precautions.
Understand the Potential Risks.
- Treatment Journey
Learn More About Treatment And
See If It's Right for Your Patients
- Safety and Side Effects
Search results
Results From The WOW.Com Content Network
The FDA on Friday also approved a second treatment for sickle cell disease, called Lyfgenia, a gene therapy from drugmaker Bluebird Bio. Both treatments work by genetically modifying a patient’s ...
This microscope photo provided on Oct. 25, 2023, by the Centers for Disease Control and Prevention shows crescent-shaped red blood cells from a sickle cell disease patient in 1972.
Sickle cell is the most common disease to receive approval for gene therapy treatment, following decades of development and years of approvals for therapy for people with rarer conditions.
UNII. S53L777GM8. KEGG. D12749. Exagamglogene autotemcel, sold under the brand name Casgevy, is a gene therapy used for the treatment of sickle cell disease [1][3] and transfusion-dependent beta thalassemia. [1] It was developed by Vertex Pharmaceuticals and CRISPR Therapeutics.
Lovotibeglogene autotemcel, sold under the brand name Lyfgenia, is a lentiviral gene therapy used for the treatment of sickle cell disease. [1] [3] [4] [5]The most common side effects include stomatitis (mouth sores of the lips, mouth, and throat), low levels of platelets, white blood cells, and red blood cells, and febrile neutropenia (fever and low white blood cell count), consistent with ...
Diseases such as sickle cell disease for which a person's normal phenotype or cell function may be restored in cells that have the disease by a normal copy of the gene that is mutated, may be a good candidate for gene therapy treatment. The risks and benefits related to gene therapy for sickle cell disease are not known. [191]
Ads
related to: gene therapy for sickle cell disease treatment